NSCLC
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients who underwent thoracoscopic sublobar, lobar, compound lobe or pneumonectomy with or without mediastinal lymph node resection; 2. Postoperative pathological diagnosis of primary non-small cell lung cancer stage I, IIA or carcinoma in situ; 3. Aged 18-85 years; 4. Voluntarily participate in clinical trials, sign informed consent, and be able to contact follow-up.
Exclusion criteria
Exclusion criteria: 1. Patients with secondary lung cancer; 2. Combined with serious primary diseases of the heart, brain, kidney and other serious diseases; 3. Mental patients; 4. Those who meet the diagnostic criteria for non-small cell lung cancer but have undergone surgery, radiotherapy, chemotherapy, targeted therapy and received traditional Chinese medicine within the past 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TCM constitution;TCM Syndrome Elements; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pathological tissue type; | — |
Countries
China
Contacts
Peking University People's Hospital